Dopamine responsive conditions
Drug Safety Update
Dopamine agonists have been associated with excessive daytime sleepiness and sudden onset of sleep. Patients starting on these drugs should be warned of the possibility of these effects and the need for caution if driving or operating machinery
Bromocriptine and cabergoline are included in this section for their inhibition of prolactin release. Cabergoline has the advantage of once weekly administration, it is contraindicated during pregnancy. See here for the use of dopamine receptor agonists in Parkinsons Disease.